David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 9.3% |
| 2 | Healthcare | 8.21% |
| 3 | Consumer Discretionary | 8.05% |
| 4 | Energy | 7.7% |
| 5 | Technology | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Brixmor Property Group
BRX
$9.08B
| $11.8M | 0.02% |
553,650
+51,356
| +10% | +$1.08M |
|
|
KMR
927
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
| $11.8M | 0.02% |
173,017
-181,502
| -51% | -$12.6M |
|
928
Ameriprise Financial
AMP
$49.6B
| $11.8M | 0.02% |
107,059
-140,162
| -57% | -$15.3M |
|
929
Adeia
ADEA
$2.9B
| $11.8M | 0.02% |
1,882,168
-563,186
| -23% | -$3.07M |
|
930
SAP
SAP
$252B
| $11.8M | 0.02% |
144,633
+82,955
| +134% | +$6.58M |
|
931
CALL
Elevance Health
ELV
$87.3B
| $11.8M | 0.02% |
118,100
-17,200
| -13% | -$1.56M |
|
|
UTEK
932
DELISTED
Ultratech Inc.
UTEK
| $11.7M | 0.02% |
402,401
+62,869
| +19% | +$1.68M |
|
933
CALL
Emerson Electric
EMR
$87.9B
| $11.7M | 0.02% |
175,700
-40,000
| -19% | -$2.63M |
|
|
PRMW
934
DELISTED
Primo Water Corporation
PRMW
| $11.7M | 0.02% |
1,383,345
+484,711
| +54% | +$3.9M |
|
935
Emergent Biosolutions
EBS
$266M
| $11.7M | 0.02% |
462,548
-10,426
| -2% | -$263K |
|
936
Reinsurance Group of America
RGA
$16B
| $11.7M | 0.02% |
146,609
-134,972
| -48% | -$10.2M |
|
937
PUT
Lowe's Companies
LOW
$122B
| $11.6M | 0.02% |
238,200
-302,600
| -56% | -$14.6M |
|
938
CALL
Berkshire Hathaway Class B
BRK.B
$1.08T
| $11.6M | 0.02% |
93,200
-470,300
| -83% | -$55M |
|
939
Medtronic
MDT
$119B
| $11.6M | 0.02% |
189,242
-668,767
| -78% | -$39M |
|
940
PUT
Hain Celestial
HAIN
$75.8M
| $11.6M | 0.02% |
254,200
-64,000
| -20% | -$2.92M |
|
941
PUT
Stryker
SYK
$126B
| $11.6M | 0.02% |
142,700
+42,900
| +43% | +$3.41M |
|
942
PUT
Nu Skin
NUS
$232M
| $11.6M | 0.02% |
140,100
-102,800
| -42% | -$9.03M |
|
|
PPLI
943
PUT
People Inc
PPLI
$2.89B
| $11.6M | 0.02% |
908,694
+241,162
| +36% | +$3.1M |
|
944
PUT
State Street
STT
$52.4B
| $11.6M | 0.02% |
166,700
-25,000
| -13% | -$1.73M |
|
945
PUT
DaVita
DVA
$11.3B
| $11.6M | 0.02% |
168,200
-48,700
| -22% | -$3.24M |
|
946
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.59B
| $11.6M | 0.02% |
202,400
-7,600
| -4% | -$419K |
|
947
CALL
Cognizant
CTSH
$28B
| $11.5M | 0.02% |
227,800
-395,400
| -63% | -$19.8M |
|
948
Cimpress
CMPR
$2.13B
| $11.5M | 0.02% |
234,105
-69,142
| -23% | -$3.5M |
|
949
Deere & Co
DE
$175B
| $11.5M | 0.02% |
+126,891
| New | +$11.1M |
|
950
PUT
Ross Stores
ROST
$77.5B
| $11.5M | 0.02% |
322,000
-11,200
| -3% | -$397K |
|
Similar funds
David Shaw's Q1 2014 Portfolio in Review
As of Q1 2014, David Shaw held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 9.3% of assets, up from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Veren worth $53.3M.
- David Shaw's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- David Shaw added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- David Shaw's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- David Shaw fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- David Shaw's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- David Shaw opened 596 new positions and closed 795 in Q1 2014.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.